Efficacy and Safety of an NRTI-Sparing Dual Regimen of Raltegravir and Ritonavir-Boosted Protease Inhibitor in a Triple Antiretroviral Class-Experienced Population
Allavena, C., Mounoury, O., Rodallec, A., Reliquet, V., Billaud, E., Raffi, F.Volume:
10
Language:
english
Journal:
HIV Clinical Trials
DOI:
10.1310/hct1005-337
Date:
September, 2009
File:
PDF, 162 KB
english, 2009